IL18 and Anxiety: Results indicated that intranasal dantrolene nanoparticle treatment robustly inhibited LPS-induced increases in depressive and anxiety behavior, LPS-induced pathological elevation of IL-1β and IL-18 levels in the blood and brain, and LPS-induced activation of pyroptosis.